ENAXTUZ Trademark
Trademark Overview
On Thursday, January 29, 2026, a trademark application was filed for ENAXTUZ with the United States Patent and Trademark Office. The USPTO has given the ENAXTUZ trademark a serial number of 99623454. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Thursday, May 28, 2026. This trademark is owned by Pfizer Inc.. The ENAXTUZ trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use
General Information
| Serial Number | 99623454 |
| Word Mark | ENAXTUZ |
| Filing Date | Thursday, January 29, 2026 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Thursday, May 28, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 29, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Pfizer Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10001-2192
US |
Trademark Events
| Event Date | Event Description |
| Thursday, January 29, 2026 | NEW APPLICATION ENTERED |
| Thursday, January 29, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, January 29, 2026 | APPLICATION FILING RECEIPT MAILED |
| Thursday, May 28, 2026 | ASSIGNED TO EXAMINER |
| Thursday, May 28, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
